What once seemed like an unattainable goal may soon be within our grasp. Learn how Johnson & Johnson is working toward its vision to create a world without cancer.| JNJ.com
The post The August 2025 <em>News from ECOG-ACRIN</em> blog is now available appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The FDA has agreed to review GSK’s request to approve Blenrep as a second-line combination treatment for multiple myeloma.| Rare Cancer News